The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.
about
Angiostatin binds ATP synthase on the surface of human endothelial cellsPlasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesisEndothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatinHold that line. Angiomotin regulates endothelial cell motilityTetranectin Binds to the Kringle 1-4 Form of Angiostatin and Modifies Its Functional ActivityDifferentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progressionFamiliar drugs may prevent cancerColey's toxin revisited: immunotherapy or plasminogen activator therapy of cancer?Purification and characterization of A61. An angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors.Angiostatin generating capacity and anti-tumour effects of D-penicillamine and plasminogen activators.Homeostatic control of angiogenesis: A newly identified function of the liver?The cytoprotective drug amifostine modifies both expression and activity of the pro-angiogenic factor VEGF-A.Future prospects in prostate cancer.Anticancer drug targets: approaching angiogenesisPlasminogen activator inhibitor-1 and the kidney.Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis.Proteolytic activity of prostate-specific antigen (PSA) towards protein substrates and effect of peptides stimulating PSA activityPlasmin-induced migration requires signaling through protease-activated receptor 1 and integrin alpha(9)beta(1).Blood vessels are regulators of growth, diagnostic markers and therapeutic targets in prostate cancer.Biological regulation through protein disulfide bond cleavage.N-acetyl-cysteine promotes angiostatin production and vascular collapse in an orthotopic model of breast cancer.Molecular targets in the inhibition of angiogenesis.Inhibition of tumor angiogenesis by angiostatin: from recombinant protein to gene therapy.Concept, mechanisms and therapeutics of angiogenesis in cancer and other diseases.Tumor angiogenesis as a target for dietary cancer preventionWhat the structure of angiostatin may tell us about its mechanism of action.Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular MatrixAdenoviral vector expressing murine angiostatin inhibits a model of breast cancer metastatic growth in the lungs of mice.Progress report on the potential of angiogenesis inhibitors for neuro-oncology.β2-Glycoprotein I Inhibits Vascular Endothelial Growth Factor-Induced Angiogenesis by Suppressing the Phosphorylation of Extracellular Signal-Regulated Kinase 1/2, Akt, and Endothelial Nitric Oxide Synthase.Role of plasminogen activator inhibitor-1 in urokinase's paradoxical in vivo tumor suppressing or promoting effectsAngiostatin-mediated suppression of cancer metastases by primary neoplasms engineered to produce granulocyte/macrophage colony-stimulating factor.Addition of an induction regimen of antiangiogenesis and antitumor immunity to standard chemotherapy improves survival in advanced malignanciesEnzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.Live-cell imaging demonstrates extracellular matrix degradation in association with active cathepsin B in caveolae of endothelial cells during tube formation.Inhibition of Nm23H2 gene product (NDPK-B) by angiostatin, polyphenols and nucleoside analogs.Reduction of tumor angiogenesis induced by desmopressin in a breast cancer modelAngiogenesis and hypertension: an update.Border patrol: insights into the unique role of perlecan/heparan sulfate proteoglycan 2 at cell and tissue bordersPathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.
P2860
Q22009028-E8B2E275-20EB-4F68-8124-70587B8DDABEQ24293734-4133254A-725E-478A-9B70-8D0B36B38E57Q24601633-B803A793-9910-4712-A245-7928858577B5Q24652767-67ABC9F5-43A1-4821-BA7B-A144AF93F82BQ24804463-4CEBF7D7-2B6A-49B2-8666-41089670A5A0Q28144159-56F19678-C30B-4573-93FB-C4C152B47981Q28186835-1C8985C7-6CC4-41FF-9224-7339D3FDD6EAQ28238042-82BB4191-FC8B-4DF4-9A02-2265A8B0F253Q31677470-050F77F0-243F-443E-9A0F-093B34FD22F2Q33245745-0592BBD8-56E9-435C-9FF6-53A125D4C9F1Q33537473-831D8943-ADC1-4B70-A871-139EBD09CD62Q33545423-AED0706E-7D90-4359-A1B1-D5EA0A2D153FQ33695955-0821C061-DBD1-4579-9D93-6F27F7B9BF32Q33787870-D9003E04-4156-4406-A4F5-A3DB8797B78DQ33960082-3B4277A5-C481-422B-AC21-3208A1B2A396Q34130552-C06FF5D3-986C-4916-A2D3-3C804B0B2256Q34215885-159E5C7C-7F84-4A1A-993B-6EFDBE15DDABQ34332597-AA7F40E0-7DDF-4269-A68A-1C7B9F3D1B1FQ34534087-E1FD9F14-32C1-4C5F-B210-202F2D0A33A8Q34790926-D2ECDDB1-3B37-4DC7-9BD7-A3AC145E37B5Q35098081-4B7F5105-177C-4DAF-B169-E4BA9A81AC1EQ35186667-750C23E0-8422-45A8-B359-C81EFEAE1ED1Q35193397-F0FACF52-930F-4631-ACB0-30A9AF64CFD7Q35212402-6D588A2D-1449-410E-8434-58D7612FD7DCQ35250910-B131DF72-4C81-4B4B-80D7-9526FC3A349FQ35626569-B24E97E4-554E-4AA9-ADE3-10CFC3FFE7DFQ35679807-00A22365-66C6-4223-ABB7-3AA8C80EAEA8Q35746748-FBF0EC84-82B4-4ED2-A284-E2D679D5585FQ35964419-ACE435C9-39CE-493F-9F2B-8488A5E8EE22Q36118474-A4BE15E3-83C5-4082-8C43-571BFA86F992Q36391616-39E265D3-7B84-42B6-A15C-E718E4F4E0ECQ36404042-AFC13244-BDB0-4FC6-8812-D8CCD228B441Q36420816-A7CDD630-5C55-4A8B-8DBA-733C0EC634FCQ37078275-FFD4FC00-ABA3-4AE0-B9FE-B501432E1863Q37181208-074A717B-CAB8-4381-9DF9-DEDCC59FA5FEQ37243131-79C8C972-44F6-4392-A88D-998D78C73310Q37302108-DDB47A5A-D59D-4A66-ACB9-3A50B6DF0C33Q37579043-765EFC3B-55C4-45FE-BAB2-A585393ACE2AQ37610826-CE8C489F-B36F-41C7-9D92-55D9F913624BQ37721597-D4D727C2-A9A0-4C9D-B18C-053B26CE87C2
P2860
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
The mechanism of cancer-mediat ...... genesis inhibitor angiostatin.
@ast
The mechanism of cancer-mediat ...... genesis inhibitor angiostatin.
@en
type
label
The mechanism of cancer-mediat ...... genesis inhibitor angiostatin.
@ast
The mechanism of cancer-mediat ...... genesis inhibitor angiostatin.
@en
prefLabel
The mechanism of cancer-mediat ...... genesis inhibitor angiostatin.
@ast
The mechanism of cancer-mediat ...... genesis inhibitor angiostatin.
@en
P2093
P2860
P356
P1476
The mechanism of cancer-mediat ...... ogenesis inhibitor angiostatin
@en
P2093
D L Cundiff
F J Castellino
P Twardowski
R A Kramer
P2860
P304
10868-10872
P356
10.1073/PNAS.94.20.10868
P407
P577
1997-09-01T00:00:00Z